phosphoserine has been researched along with (2e,4e,6e,10e)-3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Friedman, SL; Kojima, S; Matsushima-Nishiwaki, R; Moriwaki, H; Okuno, M; Takano, Y | 1 |
1 other study(ies) available for phosphoserine and (2e,4e,6e,10e)-3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid
| Article | Year |
|---|---|
Molecular mechanism for growth suppression of human hepatocellular carcinoma cells by acyclic retinoid.
Topics: Antineoplastic Agents; Blotting, Western; Carcinoma, Hepatocellular; Cell Cycle Proteins; Cell Division; Dual Specificity Phosphatase 1; Humans; Immediate-Early Proteins; Liver Neoplasms; Luciferases; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Mutagenesis, Site-Directed; Phosphoprotein Phosphatases; Phosphorylation; Phosphoserine; Protein Phosphatase 1; Protein Tyrosine Phosphatases; ras Proteins; Receptors, Retinoic Acid; Response Elements; Retinoid X Receptors; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Transfection; Tretinoin; Tumor Cells, Cultured | 2003 |